At close: December 13 at 4:00:01 PM EST
After hours: 7:59:18 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-32,558.0000
-32,558.0000
-19,155.0000
-58,457.0000
-51,767.0000
Investing Cash Flow
20,631.0000
20,631.0000
1,877.0000
-917.0000
-13,370.0000
Financing Cash Flow
-1,966.0000
-1,966.0000
-1,828.0000
26,819.0000
-1,177.0000
End Cash Position
70,605.0000
70,605.0000
84,225.0000
103,756.0000
136,792.0000
Capital Expenditure
-2,351.0000
-2,351.0000
-1,122.0000
-1,330.0000
-11,282.0000
Issuance of Debt
--
--
--
28,700.0000
1,360.0000
Repayment of Debt
-2,361.0000
-2,361.0000
-2,026.0000
-2,069.0000
-2,245.0000
Free Cash Flow
-34,909.0000
-34,909.0000
-20,277.0000
-59,787.0000
-63,049.0000
12/31/2020 - 10/17/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PCSA Processa Pharmaceuticals, Inc.
1.1100
-11.20%
TRVI Trevi Therapeutics, Inc.
4.1700
+15.83%
SLXN Silexion Therapeutics Corp
3.5200
+5.39%
PBM Psyence Biomedical Ltd.
1.8500
-9.31%
PALI Palisade Bio, Inc.
1.7700
-25.00%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.8100
+2.26%
DBVT DBV Technologies S.A.
3.5700
-7.03%
CRDF Cardiff Oncology, Inc.
3.9200
+19.88%
CDIO Cardio Diagnostics Holdings, Inc.
1.2600
+5.00%
SXTP 60 Degrees Pharmaceuticals, Inc.
1.4100
-14.55%